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The sequelae ofgram-negative bacterial sep-
sis are a major cause of morbidity and a
leading cause ofdeath in the United States
(1). Gram-negative bacteria are a normal
constituent ofthe gastrointestinal tract, and
pathogenesis from these organisms can arise
during systemic exposure to either whole
bacteria or their constituents. Such expo-
sure can occur through increased transloca-
tion of bacteria from the gut to the portal
circulation during surgery and during a
wide range of disease states, including uri-
nary tract infections, inflammatory bowel
disease, obstructive jaundice, liver disease,
and cirrhosis (2-4).
Lipopolysaccharide (LPS) is a major
component ofthe cell wall ofgram-negative
bacteria and is likely responsible for many of
the events that occur during sepsis (5).
Exposure to LPS can produce an array of
pathophysiological changes similar to those
seen during sepsis, including hypotension
and multi-organ failure involving damage to
the liver, lungs, kidneys, heart, and gastroin-
testinal tract (6). Neutrophils (PMNs) have
been implicated as playing a critical role in
LPS-induced tissue damage (7,8). After an
intravenous administration of LPS to rats,
PMNs accumulate in the liver sinusoids
within 1 hr, and multifocal, midzonal hepat-
ic necrosis is prominent by 6 hr (8,9).
Depletion of circulating PMNs before LPS
exposure protects against hepatic injury,
indicating a requirement for these cells
(8,10). Activation ofPMNs is likely a neces-
sary step in producing PMN-mediated tis-
sue injury, and studies in vitrohave demon-
strated that activated PMNs can kill both
endothelial cells and hepatocytes (11-13).
Although the exact mechanisms of PMN-
mediated tissue injury are unknown, they
probably involve production ofreactive oxy-
gen species such as the superoxide anion
(°2-) and/or release of cytotoxic enzymes
containedwithin granules (14).
Polychlorinated biphenyls (PCBs) are
industrial chemicals that have been
released into the environment. In experi-
mental animals, these compounds produce
an array oftoxic responses including hepa-
totoxicity and alterations in the immune
system (15,16). Humans accidentally
exposed to high concentrations of PCBs
expressed changes in immune system para-
meters such as alterations in lymphocyte
subpopulations and suppression ofcellular
immunity (17-19). In addition, mono-
cytes and PMNs obtained from individuals
exposed to PCBs had lower percentages of
cells bearing immunoglobulin and comple-
ment receptors (20). Primates exposed to
PCBs have exhibited a wide range of
adverse responses including inflammatory
lesions in the liver (21,22), and abnormal
liver function tests have been reported in
exposed human populations (19).
Although immunotoxicity due to PCB
exposure has been described in some detail,
less is known about the interactions ofthese
compounds with PMNs or inflammatory
responses. PCBs rapidly activate PMNs in
vitroto produce (Y° and to degranulate (23).
PMN activation by PCBs occurs through
signal transduction pathways involving
phosphoinositide hydrolysis, inositol
triphosphate production, phospholipase A2
activation, and Ca2+ mobilization (24-26).
Activation of PMNs results in production
and release of cytotoxic mediators into the
extracellular environment. Moreover, expo-
sure to PCBs in vitro alters PMN responses
to subsequent stimuli (23). Enhanced PMN
activation or responsiveness by PCBs could
lead to increased tissue injury where PMN
involvement occurs, such as during exposure
to LPS resulting from bacterial infections or
increased translocation of bacteria from the
gut. Accordingly, since LPS-induced hepa-
totoxicity is PMN dependent, we hypothe-
sized that co-exposure to PCBs would
enhance LPS-induced liver injury. This
hypothesis was tested by exposing rats to a
minimally toxic dose ofLPS followed by the
PCB mixture Aroclor 1248 and assessing
hepatic injury. Aroclor 1248 was chosen
because this mixture of PCBs is composed
predominantly oftetrachlorinated biphenyls
and ortho-substituted congeners (27), which
activate PMNs in vitro (26). Furthermore,
ortho-substituted PCB congeners have been
identified in human biological samples, and
their potential health effects have yet to be
determined (19).
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Materials and Methods
Animals. We used female Sprague-Dawley
rats [Crl:CD BR(SD) VAF/plus, 175-220
g] for studies of LPS toxicity. Male
Sprague-Dawley retired breeder rats were
used as donors of isolated PMNs.
Hepatocytes were isolated from male
Sprague-Dawley rats (175-300 g). All ani-
mals were obtained from Charles River
Laboratories (Portage, Michigan). Animals
were maintained on a 12-hr light/dark
cycle for at least 1 week before use. Food
(rat chow, Teklad, Madison, Wisconsin)
and waterwere provided adlibitum.
Chemicals. Aroclor 1248 was purchased
from ChemService (West Chester,
Pennsylvania). Lipopolysaccharide (E. coli
0128:B12 serotype), glycogen (type II from
oyster), phorbol myristate acetate (PMA),
superoxide dismutase (SOD), ferricy-
tochrome C, cytochalasin B, guaiacol,
dimethylformamide (DMF), N-formyl-
methionyl-leucyl-phenylalanine (fMLP),
and Triton X-100 were purchased from
Sigma Chemical Co. (St. Louis, Missouri).
Histochoice fixative was purchased from
Amresco (Solon, Ohio). Collagenase type
A was purchased from Boehringer-
Mannheim Biochemicals (Indianapolis,
Indiana). Williams' medium E and gen-
tamicin were purchased from Gibco
(Grand Island, NewYork). Fetal calfserum
was purchased from Intergen (Purchase,
NewYork).
Treatmentprotocol. Female Sprague-
Dawley rats received either LPS (2 mg/kg)
or sterile saline vehicle (2 ml/kg) via a tail
vein. The animals then received either
Aroclor 1248 (50 mg/kg) or corn oil vehicle
(2 ml/kg) 90 min later by intraperitoneal
injection. We used this dosing regimen to
minimize potential effects on hepatocytes
by the PCBs alone and to maximize expo-
sure ofboth circulating and tissue-adherent
(in the liver) PMNs to PCBs. Rats were
killed 6 or 9 hr after LPS/saline exposure.
The animals were anesthetized with sodium
pentobarbital (50 mg/kg, intraperitoneal),
the abdominal cavity was exposed, and
blood was drawn from the inferior vena
cava into a syringe containing heparin.
Livers were removed, and sections were pre-
pared and immediately placed in fixative.
We used an aliquot ofplasma on the same
day to determine enzyme activities.
Assessment of hepatic injury. We
assessed hepatic injury by measuring activi-
ties of alanine aminotransferase (ALT) and
isocitrate dehydrogenase (ICDH) in plasma
by kinetic determination using a Gilford
Spectrophotometer (Sigma kits no. 59-UV
and 153-UV, respectively) (28). Liver sec-
tions were fixed, embedded in paraffin, cut
at 6 pm, stained with hematoxylin and
eosin, and coded and evaluatedwithout bias
by a veterinary pathologist. The severity of
hepatic injury was graded on a scale from 0
(no significant lesions) to 5 (severe, coalesc-
ing necrosis).
Quantification ofhepatic PMNaccu-
mulation. PMNs in liver sections were
visualized using an immunohistochemical
technique (9). Liver sections were fixed,
embedded in paraffin, and sectioned at 6
pm. Paraffin was removed from the tissue
sections with xylene before staining. PMNs
within the liver tissue were stained using a
rabbit anti-rat PMN immunoglobulin.
This anti-PMN immunoglobulin was iso-
lated from serum of rabbits immunized
with rat PMNs as described previously (8).
After incubation with the primary anti-
body, the tissue sections were incubated
with biotinylated goat anti-rabbit IgG,
avidin-conjugated alkaline phosphatase,
and Vector Red substrate to stain the
PMNs within the tissue. We assessed
hepatic PMN accumulation by averaging
the number of PMNs counted in 20 mid-
zonal, 400x fields throughout 3 separate
lobes using light microscopy. PMNs were
identified by positive staining and mor-
phology.
Isolation ofPMNs. PMNs were isolated
from the peritoneum of male Sprague-
Dawley retired breeder rats by glycogen
elicitation as described previously (29).
Isolated PMNs were resuspended in
Hanks' balanced salt solution (HBSS), pH
7.4. The percentage of PMNs in the cell
preparations was routinely >95%, and the
viability was 295% as determined by the
ability to exclude trypan blue. The PMNs
were suspended in borosilicate glass test
tubes, 12 x 75 mm (VWR, Chicago,
Illinois), at a final concentration of2 x 106
cells/ml. The isolation procedure was per-
formed at room temperature.
Detection ofsuperoxide anion produc-
tion. PMNs (2 x 106 cells) were prepared in
HBSS in a finalvolume of1 ml andexposed
to either vehide (1 p1 DMF) or to 1 or 10
pg/ml Aroclor 1248 for 30 min at 37°C.
These concentrations of PCBs were chosen
for their ability to affect PMN function in
the absence ofcytotoxicity (23,26). PMA (0
or 20 ng/ml) was then added for an addi-
tional 10 min at 37°C. We measured O°
generated during this 40-min incubation
period by the SOD-sensitive reduction of
ferricytochrome C (30). In a separate series
ofexperiments, PMNs (2 x 10 cells) were
incubated with LPS (10 or 100 pg/mi) or
vehicle (HBSS) for 10 min, followed by
exposure toArocior 1248 (1 or 10 pg/ml) or
vehicle (DMF) for an additional 30 min.
We detetected O°2 produced during this 40-
minperiod as described above.
Assessment ofPMN degranulation.
Degranulation was assessed by the release
of the enzyme myeloperoxidase (MPO),
which is containedwithin azurophilic gran-
ules. PMNs were prepared in HBSS and
pretreated with 5 pg/ml cytochalasin B for
10 min at room temperature to facilitate
release of the granules into the incubation
medium (31,32). PMNs (2 x 106 cells)
were then exposed to either vehicle (1 pl
DMF) or to 1 or 10 pg/ml Aroclor 1248
for 15 min at 37°C. We exposed PMNs to
fMLP (10 nM) for 15 min at 37°C as a
positive control. fMLP is a chemotactic
peptide derived from gram-negative bacte-
ria that binds to a G-protein-coupled
receptor, leading to PMN activation
(33,34). The incubation was terminated
byplacing the cells in an ice-water bath fol-
lowed by centrifugation at 40C. The cell-
free supernatant was collected, and MPO
activity was measured by the H202-depen-
dent oxidation of guaiacol (35,36). We
measured the change in absorbance at 470
nm over 2 min at 250C in a spectropho-
tometer and calculated MPO activity (U/i)
using a molar extinction coefficient of
26,600 (36). Lactate dehydrogenase activi-
ty (LDH) present in the cell-free super-
natant was measured according to the
method ofBergmeyer and Bernt (37) as a
marker ofcytotoxicity.
Hepatocyte-neutrophil co-cultures.
Hepatocytes were isolated according to the
method of Seglen (38) as modified by
Klaunig et al. (39). Briefly, rats were anes-
thetized with sodium pentobarbital (50
mg/kg), and the portal vein was cannulat-
ed. The liver was perfused with approxi-
mately 150 ml of Mg2+-free, Ca2+-free
HBSS followed by perfusion with 250 ml
collagenase type A (0.5 mg/ml). The result-
ing liver digest was filtered through gauze
and spun in a centrifuge at 50gfor 2 min.
The hepatocytes were resuspended in
Williams' medium E containing 10% fetal
calf serum and 0.1% gentamicin. Using
this isolation procedure, 98% ofthe cells in
the final preparation were hepatic
parenchymal cells with viability routinely
>90% (13).
The hepatocytes were plated in six-well
plates at a density of 5 x 105 hepato-
cytes/well. After an initial 3-hr attachment
period, the medium and unattached cells
were removed, and either Williams' medi-
um E containing 0.1% gentamicin or
medium containing isolated PMNs was
added. PMNs were isolated as previously
described and plated at a density of 5 x
106 PMNs/well, resulting in a ratio of 10
PMNs/hepatocyte. PMNs were allowed to
attach for 30 min, then vehicle (2 pl
DMF) or Aroclor 1248 (1 or 10 pg/ml)
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Figure 1. Superoxide anion (Oi ) production by
neutrophils during exposure to Aroclor 1248 and
phorbol myristate acetate (PMA). Rat PMNs were
exposed to either 0, 1, or 10 pg/ml Aroclor 1248 for
30 min at 37°C. The PMNs were then exposed to
either 0 or 20 ng/ml PMA for an additional 10 min
at370C. °2 produced during the incubation period
was determined as described in Materials and
Methods; N = 3-4. *Significantly different from
respective value in the absence of Aroclor 1248,
one-way ANOVA(p<0.05).
Table 1. Neutrophil degranulation in the presence
ofAroclor 1248a
Treatment MPO activity (U/I)
Vehicle control 5.6 ± 3.2
Aroclor 1248 (1 pg/ml) 29.2± 19.1
Aroclor 1248 (10 pg/ml) 87.6 ± 42.9*
fMLP(10 nM) 291.8 ± 84.6*
Abbreviations: MPO, myeloperoxidase; fMLP,
formyl-methionyl-leucyl-phenylalanine.
aRat neutrophils were pretreated with 5 pg/ml
cytochalasin B for 10 min at room temperature.
Neutrophils werethen exposed tothevarious stimuli
for 15 min at 37°C. Degranulation was determined
by measuring the activity of MPO in the medium as
described in Materials and Methods; N= 4.
*Significantly different from vehicle control, one-
wayANOVA (p <0.05).
was added to wells containing either hepa-
tocytes alone or hepatocytes plus PMNs.
After a 16-hr incubation at 37°C in 92.5%
02/7.5% CO2, the medium was collected.
Previous studies have demonstrated that
PMN-mediated hepatocellular toxicity in
co-culture occurs by 16 hr after stimula-
tion of PMNs (13). The cells remaining
on the plate were lysed with 1% Triton X-
100, followed by sonication. Both the
medium and the cell lysates were spun in a
centrifuge at 600gfor 10 min. The activity
of ALT in the cell-free supernatant fluids
was determined (using Sigma kit no. 59-
UV), and the activity in the medium was
expressed as a percentage of total activity
(activity in the medium plus activity in the
cell lysates). ALT activity in PMNs is rela-
tively small and is not changed upon expo-
sure to Aroclor 1248 (data not shown).
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Figure 2. Aroclor 1248 enhances hepatic injury 6 hr after lipopolysaccharide (LPS) exposure. Animals
received either LPS (2 mg/kg, intraperitoneal) or saline followed 90 min later by treatment with either
Aroclor 1248 (50 mg/kg, intraperitoneal) or corn oil vehicle. They were killed 6 hr after LPS or saline expo-
sure, and plasma activities of(A) alanine aminotransferase (ALT) and (B) isocitrate dehydrogenase (ICDH)
were determined; N= 5-11. *Significantly different from respective value in the absence of LPS (p<0.05);
tsignificantly differentfrom respective value inthe absence ofAroclor 1248 (p<0.05).
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Figure 3. Aroclor 1248 enhances hepatic injury 9
hr after lipopolysaccharide (LPS) exposure.
Animals received either LPS (2 mg/kg, intra-
venous) or saline followed 90 min later by treat-
mentwith eitherAroclor 1248 (50 mg/kg, intraperi-
toneal) or corn oil vehicle. They were killed 9 hr
after LPS or saline exposure, and plasma alanine
aminotransferase (ALT) activity was determined;
N = 4- 1. *Significantly different from respective
value in the absence of LPS (p< 0.05); tsignificant-
ly different from respective value in the absence
ofAroclor 1248(p<0.05).
ALT is a sensitive and specific indicator of
hepatocellular damage in the rat, and in
the co-culture system release ofALT from
hepatocytes correlates with cell death mea-
sured by uptake of trypan blue and elec-
tron microscopy (13). Therefore, we used
ALT activity in the medium as an index of
injury to the hepatocytes. To examine the
mechanism by which Aroclor 1248 inter-
acts with PMNs and kills hepatocytes,
hepatocytes were cultured with cell-free
conditioned medium from PMNs exposed
to Aroclor 1248. PMNs in suspension (2.5
x 106 cells/ml Williams' medium E con-
taining 0.1% gentamicin) were pretreated
with cytochalasin B (5 pg/ml) for 10 min
at room temperature and then exposed to
either vehicle (1 1il DMF/ml cells) or
Aroclor 1248 (10 pg/mI) for 30 min at
370C. The cells were removed by centrifu-
gation, the cell-free supernatant was col-
lected and added to the hepatocytes (2
ml/well), and release of ALT was deter-
mined 16 hr later as described above (13).
Statistical analysis. All results are pre-
sented as means ± standard error of the
mean (SEM). For all results presented, N
represents the number of individual ani-
mals and in vitro repetitions. Unless other-
wise stated, data were analyzed by a two-
way analysis of variance (ANOVA), and
individual comparisons were performed
using the least significant difference test.
When variances were not homogenous,
data were log-transformed before analysis.
When appropriate, an oudier test (test for
detection of extreme means) was applied
(40). The criterion for statistical signifi-
cance wasp<0.05.
Results
Neither exposure ofPMNs to vehicle nor to
1 pg/ml Aroclor 1248 resulted in genera-
tion of °2- (Fig. 1). However, PMNs
exposed to 10 pg/ml Aroclor 1248 pro-
duced a significant amount of O°. PMA
alone caused an increase in Oi- production.
Exposure to 1 pg/ml Aroclor 1248 before
stimulation with PMA caused significant
generation ofO2- The amount of °2 pro-
duced in the presence of 1 pg/ml Aroclor
1248 and PMAwas greater than the sum of
Oi- produced individually by these two
agents. Pretreatment of PMNs with LPS
did not alter Qi production in response to
Aroclor 1248 (data notshown).
Exposure to 10 pg/ml, but not 1 pg/ml,
Arodor 1248 elicited a significant release of
MPO from PMNs compared to vehicle
control (Table 1). Release ofMPO into the
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Table 2. Aroclor 1248 potentiation of LPS-induced hepatotoxicity: histopathologic evaluationa
% Rats with histopathologic score
Treatment N 0 1 2 3 4 5
Saline/corn oil 5 100
Saline/Aroclor 5 100
LPS/corn oil 11 27 18 36 18
LPS/Aroclor 9 11 11 33 22 22
LPS, lipopolysaccharide.
aRats received either LPS (2 mg/kg, intravenous) or saline and 90 min later received either Aroclor 1248
(50 mg/kg, intraperitoneal) or corn oil vehicle. Animals were killed 6 hr after administration of LPS or
saline, and liver sections were prepared from three different lobes. Severity of hepatic injury was graded
on a scale of 0-5 reflecting the frequency and size of the hepatic lesions: 0 = no significant lesions; 1 =
extremely mild necrosis; 2 = mild necrosis; 3 = moderate necrosis; 4 = marked necrosis; 5 = severe, coa-
lescing necrosis.
Figure 4. Photomicrographs of liver sections taken 6 hr after lipopolysaccharide (LPS) administration. (A)
Liver from corn oil-treated animal given LPS had sinusoidal neutrophilia and a small lesion (arrow). (B)
Liver from animal treated with Aroclor 1248 and LPS had sinusoidal neutrophilia and marked midzonal
necrosis. Bar = 50 pm.
medium occurred in the absence of cyto-
toxicity as determined by release of LDH
(data not shown). PMN degranulation in
response to fMLP was included as a posi-
tive control.
Six hours after exposure to LPS alone,
activities of ALT and ICDH in plasma
were not significantly elevated (Fig. 2).
Administration of Aroclor 1248 (50
mg/kg) 90 min after LPS exposure resulted
in significant hepatic injury, as demonstrat-
ed from increased activities of ALT and
ICDH (Fig. 2). Exposure to Aroclor 1248
in the absence of LPS had no effect on
ALT or ICDH activities in plasma. Nine
hours after administration of LPS alone,
plasma ALT activity was increased com-
pared to controls (Fig. 3). Activity ofALT
in plasma of rats treated with Aroclor fol-
lowing LPS was significantly greater than
in rats receiving LPS alone. Co-administra-
tion ofAroclor 1248 with LPS resulted in
lethality in 10% of the animals. Lethality
was not seen in animals treated with LPS
or Aroclor 1248 alone. In a separate study,
administration ofa smaller dose ofAroclor
1248 (10 mg/kg) did not affect LPS-
induced hepatic injury as determined by
activities of ALT and ICDH in plasma
(data not shown). Exposure to a larger dose
ofAroclor 1248 alone (100 mg/kg) did not
produce hepatic injury, as evidenced from
activities ofALT and ICDH in plasma (74
± 9 and 6 ± 1 U/l, respectively; not signifi-
cantly different from vehicle controls) and
histologic evaluation.
There were no significant lesions in the
livers ofvehicle-treated rats or rats exposed
to Aroclor 1248 in the absence of LPS
(Table 2). Six hours after LPS administra-
tion, livers from animals co-treated with
either Aroclor 1248 or corn oil vehicle had
lesions of varying degrees of severity (Fig.
4). The hepatic sinusoids of LPS-treated
rats contained many PMNs, plump
Kupffer cells, and small amounts of an
eosinophilic, proteinaceous material. There
were multifocal, irregularly shaped areas of
midzonal hepatocellular necrosis. These
lesions were characterized by hyper-
eosinophilic parenchymal cells with small,
pyknotic nuclei or by swollen, pale
parenchymal cells with indistinct to absent
nuclei and indistinct cytoplasmic borders.
The necrotic foci contained degenerate
PMNs. There were also foci of single-cell
necrosis scattered throughout the tissue.
Aroclor 1248 administration increased the
severity of the hepatic lesions, but the
nature ofthe lesions did not change.
PMNs were observed infrequently
throughout the liver tissue from animals
exposed to saline, regardless of co-treat-
ment with Aroclor 1248 (Fig. 5). A marked
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accumulation of PMNs was observed at 6
hr in livers from animals exposed to LPS,
and this was not affected by co-administra-
tion ofAroclor 1248.
Isolated hepatocytes, either in the pres-
ence or absence ofPMNs, were exposed to
various concentrations ofAroclor 1248 for
16 hr (Fig. 6). Neither 1 pg/ml nor 10
pg/ml Aroclor 1248 was toxic to the hepa-
tocytes. Addition of PMNs to the hepato-
cyte cultures did not produce cytotoxicity
in the absence ofAroclor 1248. However,
stimulation of the PMNs with either 1
pg/ml or 10 pg/ml Aroclor 1248 resulted
in a significant release ofALT into the cul-
ture medium. In a similar experiment in
which hepatocytes were incubated with
cell-free conditioned medium from PMNs
exposed to Aroclor 1248 or its vehicle, no
significant differences were observed in
these two groups (data not shown).
Discussion
Under normal circumstances, the liver is
exposed to small amounts of gut-derived
LPS originating from gram-negative bacte-
ria residing in the gastrointestinal tract.
However, during sepsis or numerous disease
states exposure may increase, and LPS may
initiate a systemic inflammatory response
leading to significant morbidity and mortal-
ity. PMNs have been demonstrated to play
a key role in the development of organ
injury during sepsis (6). In such situations,
enhancement ofPMN activation or respon-
siveness by xenobiotic agents could lead to
increased tissue injury. The ability ofPCBs
to enhance organ injury during an inflam-
matory event was examined in a model of
LPS-induced hepatic injury. In this model,
PMNs rapidly accumulate in large numbers
in the hepatic sinusoids after administration
ofLPS and are required for development of
hepatic injury (8,10). At the dose used in
this study, rats exposed to LPS alone and
killed 6 or 9 hr later developed mild hepatic
necrosis. Administration of Aroclor 1248
increased the severity of the hepatic injury
as evidenced by elevated ALT and ICDH
activities in plasma and increased severity of
hepatic lesions determined histologically.
The pathological changes observed are con-
sistent with previous studies describing
hepatic injury in rats treated with LPS
(8,41). In addition, co-treatment with
Aroclor 1248 produced lethality, whereas
no mortality occurred in animals exposed to
LPS alone. Exposure to Aroclor 1248 alone
up to 100 mg/kg did not produce hepato-
toxicity.
These results are consistent with previ-
ous studies describing sensitization to LPS-
induced lethality by pretreatment with
PCBs. Mortality after administration of
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Figure 5 Hepatic neutrophil accumulation after
lipopolysaccharide (LPS) exposure. Animals
received either LPS (2 mg/kg, intravenous) or
saline followed 90 min later by treatment with
either Aroclor 1248 (50 mg/kg, intraperitoneal) or
corn oil vehicle. They were killed 6 hr after LPS or
saline exposure, the liver was removed, and sec-
tions prepared for immunohistochemistry as
described in Materials and Methods. PMNs were
counted in 20 400x midzonal fields throughout 3
separate lobes and averaged for each individual
animal; N = 5-11. *Significantly different from
respective value in the absence of LPS (p<0.05).
LPS was greater in mice fed Aroclor 1248
for 5 weeks compared to mice fed a control
diet (42). Similarly, mice fed Aroclor 1242
for 6 weeks were more responsive to the
lethal effects of LPS (43). Neither ofthese
studies investigated damage to the liver or
other organs. Other investigators have
described a potentiation of LPS-mediated
hepatotoxicity after exposure to com-
pounds structurally related to some PCB
congeners, i.e., 2,3,7,8-tetrachlorodibenzo-
p-dioxin and polybrominated biphenyls
(44-46). These studies involved treatment
with halogenated biphenyls before admin-
istration of LPS so that effects on hepatic
parenchymal cells, such as enzyme induc-
tion and alterations in gene expression,
were likely to have occurred before LPS
exposure and may have contributed to
potentiation of toxicity. These effects may
be related to Ah receptor-mediated events.
In the present study, the direct effects of
Aroclor 1248 on hepatic parenchymal cells
cannot be ruled out; however, the treat-
ment paradigm involved a short time (4.5
hr) between PCB exposure and evaluation
of liver injury, so effects such as enzyme
induction would be minimized.
PMNs begin accumulating in the hepat-
ic sinusoids ofrats within 30 min after LPS
administration, and this event is a prerequi-
site for development of liver injury (9).
Exposure to Aroclor 1248 did not affect
hepatic PMN accumulation in LPS-treated
rats; thus, potentiation of injury was not
caused by increased numbers of PMNs in
the liver. After absorption into the circula-
m
4- 0
.5-
10
-a
40
30
10
Aroclor1248(jig/ml)
Figure 6. Aroclor 1248 stimulates PMN-mediated
hepatocellular cytotoxicity in co-culture. Hepato-
cytes were cultured in the presence or absence of
PMNs and exposed to either 0, 1, or 10 pg/ml
Aroclor 1248. The activity of alanine aminotrans-
ferase (ALT) was determined in the cell-free medi-
um and the cell lysates 16 hr later, and the per-
centage of total ALT released was calculated as
described in Materials and Methods; N = 5.
*Significantly different from respective value in
the absence of PMNs (p<0.05).
tion, PCBs initially distribute in high con-
centration in the liver, which is a target
organ for toxicity (15,16,47). Therefore,
the presence of PCBs in the liver concur-
rent with PMN accumulation allows the
possibility that PCBs affected the PMNs
locally and that this contributed to
increased hepatocellular damage. Indeed,
isolated PMNs produced Oi- and under-
went degranulation upon exposure in vitro
to Arodor 1248, and Aroclor 1248 potenti-
ated the production of °i- in response to
PMA stimulation. PMA directly stimulates
protein kinase C, leading to activation of
the NADPH oxidase system and O°i pro-
duction (48). These data withAroclor 1248
are consistent with previous studies involv-
ing Aroclor 1242 and individual congeners
ofPCB (23,26).
PCBs initiate PMN responses within 15
min by activating the cellular signal trans-
duction pathways responsible for these func-
tions (24,26), thus providing a time-course
for PMN activation that is consonant with
the development ofhepatic necrosis in vivo.
This proposed mechanism for the enhance-
ment of LPS-induced hepatic injury by
Aroclor 1248 was supported by the results
obtained using an in vitro co-culture system
composed of isolated hepatocytes and
PMNs. Aroclor 1248 was not toxic to the
hepatocytes in the absence of PMNs; how-
ever, hepatocellular injury, as evidenced by
increased release ofALT into the medium,
occurred when hepatocytes were co-cultured
with PMNs activated upon the addition of
Aroclor 1248. The co-culture system is a
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simplified model ofevents occurring in vivo,
where PMN accumulation and adherence
occurs before administration ofAroclor
1248. Our experiments involving cell-free
conditioned medium from Aroclor 1248-
treated PMNs suggested that either cell-cell
contact between PMNs and hepatocytes is
required for the mechanism by which
Aroclor 1248 elicits PMN-mediated hepato-
cellular injury and/or the factor responsible
for cytotoxicity is not stable enough to sur-
vive the time and process involved in
preparing cell-free conditioned medium.
This is not altogether surprising because
Aroclor 1248 stimulates production of Qy
by PMNs, which is highly reactive and
short-lived. A combination ofboth reactive
oxygen species and degranulation products
may be involved in PMN-mediated killing
ofhepatocytes upon PCB exposure.
The mechanisms by which PMNs
injure hepatic tissue are not fully under-
stood. Recent studies suggest that proteases
released from PMN granules can kill both
endothelial cells and hepatocytes in vitro
(11,13). Reactive oxygen species, such as
O°, may also play a contributing role in
PMN-mediated tissue injury (14). Because
Aroclor 1248 can elicit PMN O°- produc-
tion and degranulation, both mechanisms
may contribute to potentiating PMN-
mediated tissue injury. It is also possible
that PCBs may adversely affect hepatic
parenchymal cells in a manner resulting in
greater susceptibility to injury upon expo-
sure to PMN-derived cytotoxic mediators.
In summary, Aroclor 1248 increased
the hepatic injury that follows LPS admin-
istration. Because PMNs play a critical role
in liver injury from LPS, these findings are
consistent with previous studies demon-
strating that PCBs can activate PMNs in
vitro and sensitize animals to LPS-induced
lethality. PCBs may act in a fashion analo-
gous to inflammatory stimuli by activating
PMNs to become cytotoxic, resulting in
enhancement of PMN-mediated tissue
injury during an inflammatory event.
Studies with individual PCB congeners
suggest that ortho-substituted PCBs can
activate PMNs in vitro, whereas coplanar
PCBs are inactive (23). Because Aroclor
1248 is a mixture of PCB congeners, the
respective roles for both ortho-substituted
and coplanar congeners in the mechanism
for enhanced liver injury upon LPS expo-
sure is uncertain at this time.
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